IL7R and relapsing-remitting multiple sclerosis: Our focus specifically on newly diagnosed patients with RRMS and the combination of CD25, CD127, and FOXP3 expression to define Tregs (and its subsets using HLA-DR and CD45RA) might have directed us to these observations.